SLC12A3 Positively correlates with both CD8+ and CD4+ T cells and dendritic cells, pointing to its involvement in enhancing T cell-mediated immunity and antigen presentation, which could be crucial for anti-tumor responses in ccRCC [165] (S1 Fig in S1 File). This evidence concerns the gene SLC12A3 and nonpapillary renal cell carcinoma.